A phase I dose escalation and pharmacokinetic (PK) study of intravenous (iv) aflibercept (VEGF Trap) plus weekly gemcitabine (Gem) in patients (pts) with advanced solid tumors: preliminary results

被引：0
|
作者：
Patnaik, A.
Pipas, M.
Rosen, L. S.
Wood, L.
Phipps, K.
Mulay, M.
Garay, C.
Korc, M.
Sarantopoulos, J.
机构：
[1] START, San Antonio, TX USA
[2] Dartmouth Hitchcock Med Ctr, Lebanon, NH 03766 USA
[3] Premiere Oncol, Santa Monica, CA USA
[4] Univ Texas Hlth & Sci Ctr San Antonio, Canc Therapy & Res Ctr, San Antonio, TX USA
[5] Sanofi Aventis, Malvern, PA USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2008年 / 26卷 / 15期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
3558
引用
收藏
页数：1
相关论文
共 50 条
  • [1] PHASE I DOSE ESCALATION AND PHARMACOKINETIC (PK) STUDY OF IV AFLIBERCEPT (VEGF TRAP) PLUS WEEKLY GEMCITABINE AND DAILY ERLOTINIB IN PATIENTS (PTS) WITH ADVANCED SOLID TUMORS: PRELIMINARY RESULTS
    Sarantopoulos, J.
    Rosen, L.
    Chap, L.
    Mita, A.
    Papadopoulos, K.
    Mita, M.
    Wood, L.
    Nichols, S.
    Tolcher, A.
    Trembly, J.
    Patnaik, A.
    ANNALS OF ONCOLOGY, 2010, 21 : 57 - 57
  • [2] A phase I dose escalation and pharmacokinetic (PK) study of intravenous aflibercept (VEGF trap) plus docetaxel (D) in patients (pts) with advanced solid tumors: Preliminary results
    Isambert, N.
    Freyer, G.
    Zanetta, S.
    Falandry, C.
    Lazard, K. Soussan
    Fumoleau, P.
    JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (15)
  • [3] A phase I dose escalation and pharmacokinetic (PK) study of intravenous (iv) aflibercept (VEGF Trap) plus FOLFOX4 in patients (pts) with advanced solid tumors: Preliminary results
    Limentani, S.
    Just, R.
    Purdham, A.
    Mulay, M.
    Bair, A.
    Tamby, J. F.
    Chap, L. I.
    Rosen, L. S.
    JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (15)
  • [4] A phase I dose escalation and pharmacokinetic (PK) study of intravenous (iv) aflibercept (VEGF Trap) plus docetaxel (D) and cisplatin (C) in patients (pts) with advanced solid tumors: preliminary results
    Freyer, G., Sr.
    Fumoleau, P.
    You, B.
    Isambert, N.
    Chevalier, P.
    Lenoir, V. Trillet
    JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (15)
  • [5] Phase I and pharmacokinetic (PK) study of weekly KOS-862 (Epothilone D) combined with gemcitabine (GEM) in patients (Pts) with advanced solid tumors.
    Marshall, JL
    Ramalingam, S
    Hwang, JJ
    Ramanathan, R
    Malik, S
    Egorin, M
    Hannah, A
    Cropp, GF
    Johnson, RG
    Belani, C
    JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (16) : 145S - 145S
  • [6] Sunitinib (SU) plus docetaxel (D) in patients (pts) with advanced solid tumors: a phase I dose-escalation and pharmacokinetic (PK) study
    Traynor, A.
    Sandler, A.
    Schiller, J. H.
    Ilagan, J.
    Harper, K.
    VerMeulen, W.
    Liu, G.
    Tye, L.
    Chao, R.
    Robert, F.
    EJC SUPPLEMENTS, 2007, 5 (04): : 110 - 110
  • [7] A phase I dose-escalation and pharmacokinetic (PK) study of sunitinib (SU) plus docetaxel (D) in patients (pts) with advanced solid tumors (STs)
    Robert, F.
    Sandler, A.
    Schiller, J. H.
    Ilagan, J.
    VerMeulen, W.
    Harper, K.
    Liu, G.
    Tye, L.
    Chao, R.
    Traynor, A.
    JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (18)
  • [8] Phase I dose-escalation and pharmacokinetic (PK) study of sunitinib (SU) plus docetaxel (D) in patients (pts) with advanced solid tumors (STs)
    Traynor, A. M.
    Sandler, A. B.
    Schiller, J. H.
    Ilagan, J.
    Vermeulen, W. L.
    Liu, G.
    Tye, L.
    Verkh, L.
    Chao, R.
    Robert, F.
    JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (15)
  • [9] Phase I Dose Escalation Study of Gemcitabine plus Irinotecan in Advanced Solid Tumors
    Dugan, Elizabeth
    Truax, Roxanne
    Meadows, Kellen L.
    Blobe, Gerald C.
    Morse, Michael A.
    Fernando, Nishan H.
    Gockerman, Jon P.
    Petros, William P.
    Hurwitz, Herbert I.
    ANTICANCER RESEARCH, 2009, 29 (12) : 5149 - 5153
  • [10] DOSE-ESCALATION PHASE I STUDY OF CABAZITAXEL (CBZ) plus GEMCITABINE (GEM) IN PATIENTS (PTS) WITH METASTATIC OR UNRESECTABLE ADVANCED SOLID MALIGNANCY
    Rixe, O.
    Puzanov, I.
    LoRusso, P. M.
    Yin, J.
    Doroumian, S.
    Zhi, X.
    Olszanski, A. J.
    ANNALS OF ONCOLOGY, 2012, 23 : 170 - 170
12345